Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Other Non-Current Assets (2020 - 2025)

Cellebrite DI has reported Other Non-Current Assets over the past 6 years, most recently at $14.6 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $14.6 million for Q4 2025, up 90.29% from a year ago — trailing twelve months through Dec 2025 was $14.6 million (up 90.29% YoY), and the annual figure for FY2025 was $14.6 million, up 90.29%.
  • Other Non-Current Assets for Q4 2025 was $14.6 million at Cellebrite DI, up from $7.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CLBT hit a ceiling of $14.6 million in Q4 2025 and a floor of $1.7 million in Q4 2022.
  • Median Other Non-Current Assets over the past 5 years was $7.3 million (2023), compared with a mean of $6.7 million.
  • Biggest five-year swings in Other Non-Current Assets: decreased 11.59% in 2022 and later surged 324.09% in 2023.
  • Cellebrite DI's Other Non-Current Assets stood at $2.0 million in 2021, then decreased by 11.59% to $1.7 million in 2022, then surged by 324.09% to $7.3 million in 2023, then grew by 4.65% to $7.7 million in 2024, then soared by 90.29% to $14.6 million in 2025.
  • The last three reported values for Other Non-Current Assets were $14.6 million (Q4 2025), $7.7 million (Q4 2024), and $7.3 million (Q4 2023) per Business Quant data.